Cargando…

NEDD9 Is a Positive Regulator of Epithelial-Mesenchymal Transition and Promotes Invasion in Aggressive Breast Cancer

Epithelial to mesenchymal transition (EMT) plays an important role in many biological processes. The latest studies revealed that aggressive breast cancer, especially the triple-negative breast cancer (TNBC) subtype was frequently associated with apparent EMT, but the mechanisms are still unclear. N...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kong, Chenfei, Wang, Changqing, Wang, Liping, Ma, Musong, Niu, Chunbo, Sun, Xiaoqian, Du, Juan, Dong, Zhixiong, Zhu, Shan, Lu, Jun, Huang, Baiqu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3145662/ https://www.ncbi.nlm.nih.gov/pubmed/21829474 http://dx.doi.org/10.1371/journal.pone.0022666

Ejemplares similares

Genome-Wide Analysis of Histone H3 Lysine9 Modifications in Human Mesenchymal Stem Cell Osteogenic Differentiation
por: Tan, Jiang, et al.
Publicado: (2009)

NEDD9 may regulate hepatocellular carcinoma cell metastasis by promoting epithelial-mesenchymal-transition and stemness via repressing Smad7
por: Wang, Zhipeng, et al.
Publicado: (2016)

MicroRNA-1252-5p, regulated by Myb, inhibits invasion and epithelial-mesenchymal transition of pancreatic cancer cells by targeting NEDD9
por: Xue, Yuzheng, et al.
Publicado: (2021)

NEDD9 promotes oncogenic signaling, a stem/mesenchymal gene signature, and aggressive ovarian cancer growth in mice
por: Gabbasov, Rashid, et al.
Publicado: (2018)

CDK5 is essential for TGF-β1-induced epithelial-mesenchymal transition and breast cancer progression
por: Liang, Qian, et al.
Publicado: (2013)

ERRATUM: CDK5 is essential for TGF-β1-induced epithelial-mesenchymal transition and breast cancer progression
por: Liang, Qian, et al.
Publicado: (2014)

Overexpression of NEDD9 in renal cell carcinoma is associated with tumor migration and invasion
por: Wang, Jue, et al.
Publicado: (2017)

SOX9 is a driver of aggressive prostate cancer by promoting invasion, cell fate and cytoskeleton alterations and epithelial to mesenchymal transition
por: Francis, Jeffrey C., et al.
Publicado: (2018)

Role of NEDD9 in invasion and metastasis of lung adenocarcinoma
por: CHANG, JING-XIA, et al.
Publicado: (2012)

Targeting the Metabolic Reprogramming That Controls Epithelial-to-Mesenchymal Transition in Aggressive Tumors
por: Morandi, Andrea, et al.
Publicado: (2017)

Role of MMP-9 in epithelial-mesenchymal transition of thyroid cancer
por: Li, Yuanchun, et al.
Publicado: (2020)

Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: Tumor budding as oncotarget
por: Zlobec, Inti, et al.
Publicado: (2010)

Thrombospondin 1 promotes an aggressive phenotype through epithelial-to-mesenchymal transition in human melanoma
por: Jayachandran, Aparna, et al.
Publicado: (2014)

Epithelial-Mesenchymal Transition in Keratocystic Odontogenic Tumor: Possible Role in Locally Aggressive Behavior
por: Zhong, Wen-Qun, et al.
Publicado: (2015)

Splicing factor ratio as an index of epithelial-mesenchymal transition and tumor aggressiveness in breast cancer
por: Fici, Pietro, et al.
Publicado: (2016)

HOXD9 promote epithelial‐mesenchymal transition and metastasis in colorectal carcinoma
por: Liu, Mengwei, et al.
Publicado: (2020)

Nedd4-2 and the Regulation of Epithelial Sodium Transport
por: Rotin, Daniela, et al.
Publicado: (2012)

Epithelial-mesenchymal Transition and Cell Invasion
por: Son, Hwajin, et al.
Publicado: (2010)

Conversion of epithelial-to-mesenchymal transition to mesenchymal-to-epithelial transition is mediated by oxygen concentration in pancreatic cancer cells
por: Chen, Shuo, et al.
Publicado: (2018)

Conversion of epithelial-to-mesenchymal transition to mesenchymal-to-epithelial transition is mediated by oxygen concentration in pancreatic cancer cells
por: Chen, Shuo, et al.
Publicado: (2022)

The dual function of PRMT1 in modulating epithelial-mesenchymal transition and cellular senescence in breast cancer cells through regulation of ZEB1
por: Gao, Yanyan, et al.
Publicado: (2016)

AnnexinA7 promotes epithelial–mesenchymal transition by interacting with Sorcin and contributes to aggressiveness in hepatocellular carcinoma
por: Ling, Fei, et al.
Publicado: (2021)

Impact on growth and invasion of gastric cancer cell lines by silencing NEDD9
por: Zhang, Sisen, et al.
Publicado: (2015)

EXPRESSION OF NEDD9 IN TRANSBRONCHIAL BIOPSIES OF LUNG ADENOCARCINOMA
por: Ostojić, Jelena, et al.
Publicado: (2018)

NEDD9 sustains hexokinase expression to promote glycolysis
por: Deneka, Alexander Y., et al.
Publicado: (2022)

Sox2 promotes tumor aggressiveness and epithelial-mesenchymal transition in tongue squamous cell carcinoma
por: Liu, Xingguang, et al.
Publicado: (2018)

Role of epithelial-mesenchymal transition factor SNAI1 and its targets in ovarian cancer aggressiveness
por: Suzuki, Tise, et al.
Publicado: (2023)

Let-7a inhibits migration, invasion and epithelial-mesenchymal transition by targeting HMGA2 in nasopharyngeal carcinoma
por: Wu, Aibing, et al.
Publicado: (2015)

Detection and analysis of long noncoding RNA expression profiles related to epithelial–mesenchymal transition in keloids
por: Chen, Zhixiong, et al.
Publicado: (2022)

Advances in the relationship between ferroptosis and epithelial–mesenchymal transition in cancer
por: Mu, Wenrong, et al.
Publicado: (2023)

Cortactin in Epithelial–Mesenchymal Transition
por: Ji, Rong, et al.
Publicado: (2020)

miR-107 is involved in the regulation of NEDD9-mediated invasion and metastasis in breast cancer
por: Zhou, Jiamin, et al.
Publicado: (2022)

NEDD9 overexpression: Prognostic and guidance value in acute myeloid leukaemia
por: Hua, Shenghao, et al.
Publicado: (2021)

Regulation of epithelial-mesenchymal transition by protein lysine acetylation
por: Kong, Fanyun, et al.
Publicado: (2022)

siRNA Suppression of NEDD9 Inhibits Proliferation and Enhances Apoptosis in Renal Cell Carcinoma
por: Wang, Jue, et al.
Publicado: (2015)

The Prognostic Role of NEDD9 and P38 Protein Expression Levels in Urinary Bladder Transitional Cell Carcinoma
por: Harb, Ola A., et al.
Publicado: (2017)

Melatonin attenuates hypoxia-induced epithelial-mesenchymal transition and cell aggressive via Smad7/ CCL20 in glioma
por: Chen, Xueran, et al.
Publicado: (2017)

Correction: Detection and analysis of long noncoding RNA expression profiles related to epithelial–mesenchymal transition in keloids
por: Chen, Zhixiong, et al.
Publicado: (2023)

NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma
por: Speranza, Maria Carmela, et al.
Publicado: (2012)

Matrix metalloproteinase 2 contributes to aggressive phenotype, epithelial-mesenchymal transition and poor outcome in nasopharyngeal carcinoma
por: Li, Siyi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0ufjfbpbjipm6vk1atnpp9dpdb